I read with great interest the article by Passaro et al. [1] exploring the novel perspective of glaucoma as a tau-associated disorder and shedding light on potential new therapeutic avenues for this disease through targeting various pathogenic pathways involved in tauopathies. Here, MAPT is linked to glaucoma.